Alnylam Pharma Beats Inventorship Suit Tied To COVID-19 Jab

By Lauren Berg · July 1, 2025, 11:38 PM EDT

A Delaware federal judge Tuesday tossed Acuitas Therapeutics' lawsuit seeking to have its scientists added as inventors on seven Alnylam Pharmaceuticals patents tied to mRNA technology, saying the complaint doesn't plausibly...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Acuitas Therapeutics Inc. et al v. Alnylam Pharmaceuticals, Inc.

Case Number

1:24-cv-00816

Court

Delaware

Nature of Suit

Patent

Date Filed

July 12, 2024